ERBB2 and breast cancer: MiR-21 has been suggested as a negative prognostic factor for BC, as its higher expression in invasive ductal carcinoma compared to normal breast tissue is positively associated with tumor size, stage, grade, and Ki-67 expression, as well as with ER negativity and HER2 positivity and lower overall survival rates [290].